Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ISUN, INC. (JSYN)
|
Add to portfolio |
|
|
|
| Price: |
$12.86
| | Metrics |
| OS: |
30.8
|
M
| |
|
|
| Market cap: |
$396
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
$0.67
| |
19.27
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 45.3 | 21.1 | 28.2 | 16.0 | 0.7 | 0.5 | 0.1 | 0.0 |
| Revenue growth | 115.2% | -25.4% | 76.9% | 2325.5% | 37.5% | 268.1% | 473.4% | |
| Cost of goods sold | 38.9 | 18.7 | 24.1 | 12.8 | 0.0 | 0.0 | 0.0 | 0.1 |
| Gross profit | 6.4 | 2.3 | 4.2 | 3.1 | 0.6 | 0.4 | 0.1 | -0.1 |
| Gross margin | 14.1% | 11.1% | 14.8% | 19.7% | 95.2% | 92.3% | 100.0% | -375.1% |
| Selling, general and administrative | | | | | | | | 0.0 |
| General and administrative | 13.4 | 3.3 | 2.4 | 1.2 | 1.4 | 1.0 | 0.3 | |
| EBITA | -10.3 | -1.7 | 0.9 | 1.2 | -0.7 | -0.5 | -0.1 | -0.1 |
| EBITA margin | -22.8% | -8.0% | 3.3% | 7.5% | -113.5% | -113.3% | -100.0% | -573.4% |
| Amortization of intangibles | 0.3 | | | | | | | |
| EBIT | -10.6 | -1.7 | 0.9 | 1.2 | -0.7 | -0.5 | -0.1 | -0.1 |
| EBIT margin | -23.4% | -8.0% | 3.3% | 7.5% | -113.5% | -113.3% | -100.0% | -573.4% |
| Pre-tax income | -8.2 | -1.5 | 3.6 | 1.1 | -0.6 | -0.4 | -0.1 | -0.1 |
| Income taxes | -1.9 | -0.5 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 23.5% | 33.2% | 30.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -6.3 | -1.3 | 2.5 | 0.8 | -0.6 | -0.4 | -0.1 | -0.1 |
| Net margin | -13.9% | -6.0% | 9.0% | 4.8% | -88.8% | -90.8% | -100.3% | -575.1% |
| |
| Diluted EPS | ($0.68) | ($0.24) | $0.57 | $0.24 | ($0.30) | ($0.23) | ($0.10) | ($0.10) |
| Shares outstanding (diluted) | 9.3 | 5.3 | 4.4 | 3.2 | 1.9 | 1.9 | 1.4 | 1.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|